Full name
"PROLEK" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,3 | -0 | 0,5 | 2088,5 |
Gross profit (loss) | -0 | 0,7 | 0,6 | -10,7 |
EBITDA | -0,1 | -0 | 0,5 | 13 487,9 |
Short time liabilities | 2,5 | 1,7 | 2 | 18,4 |
Other operating costs | 0 | 0 | 0 | -64,7 |
Equity capital | 0 | 0,6 | 1,1 | 68,4 |
Operating profit (EBIT) | -0,1 | -0 | 0,5 | 7312,7 |
Assets | 2,5 | 2,3 | 3,1 | 32,1 |
Net profit (loss) | -0 | 0,6 | 0,4 | -32,2 |
Cash | 1 | 0,8 | 1,2 | 52,7 |
Net income from sale | 11,8 | 12,2 | 13 | 6,2 |
Liabilities and provisions for liabilities | 2,5 | 1,7 | 2 | 18,4 |
Working assets | 2,5 | 2,3 | 3,1 | 32,1 |
Other income costs | 0,2 | 0,1 | 0 | -50,1 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | -38 | 100,9 | 40,6 | -60,3 |
Equity capital to total assets | 2 | 27,4 | 34,9 | 7,5 |
Gross profit margin | -0,2 | 5,9 | 5 | -0,9 |
EBITDA Margin | -1 | -0 | 3,7 | 3,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 76 | 50 | 56 | 6 |
Current financial liquidity indicator | 0.9963903427124023 | 1.3771120309829712 | 1.5365499258041382 | 0,1 |
Net dept to EBITDA | 7.60321044921875 | 205.9086456298828 | -2.5151207447052 | -208,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane